Majority of women with early-stage breast cancer undergoing imaging despite guidelines
the ONA take:
According to a new study published in the Canadian Medical Association Journal, researchers have found that the majority of women with early-stage breast cancer undergo imaging for metastatic cancer despite guidelines from three organizations that recommend against imaging for metastatic cancer in asymptomatic women with early-stage breast cancer.
For the study, researchers identified 26,547 women with stage I or II breast cancer diagnosed between 2007 and 2012 in Ontario, Canada.
Of those, 86% underwent at least one imaging test to detect whether the patient had developed metastatic cancer.
Specifically, imaging was performed in 80% and 93% of patients with stage I and stage II breast cancer, respectively.
The American Society of Clinical Oncology, the National Comprehensive Cancer Network, and Cancer Care Ontario recommend against imaging for the detection of metastatic cancer in asymptomatic women with stage I or II breast cancer due to the very low likelihood of metastases.
There is also a high risk for false-positives that can result in further unnecessary tests, costs, and worry.
The majority of women with early-stage breast cancer undergo imaging for metastatic cancer despite guidelines.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Patients and Caregivers Worry About Cost of Cancer Care
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|